Cargando…
Mesenchymal Stem Cells As Guideposts for Nanoparticle-Mediated Targeted Drug Delivery in Ovarian Cancer
Nanocarriers have been extensively utilized for the systemic targeting of various solid tumors and their metastases. However, current drug delivery systems, in general, suffer from a lack of selectivity for tumor cells. Here, we develop a novel two-step targeting strategy that relies on the selectiv...
Autores principales: | Layek, Buddhadev, Shetty, Mihir, Nethi, Susheel Kumar, Sehgal, Drishti, Starr, Timothy K., Prabha, Swayam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226169/ https://www.ncbi.nlm.nih.gov/pubmed/32295145 http://dx.doi.org/10.3390/cancers12040965 |
Ejemplares similares
-
Pharmacokinetic—Pharmacodynamic Modeling of Tumor Targeted Drug Delivery Using Nano-Engineered Mesenchymal Stem Cells
por: Cheng, Shen, et al.
Publicado: (2021) -
Improving Payload Capacity and Anti-Tumor Efficacy of Mesenchymal Stem Cells Using TAT Peptide Functionalized Polymeric Nanoparticles
por: Moku, Gopikrishna, et al.
Publicado: (2019) -
Enhancing Anticancer Efficacy of Chemotherapeutics Using Targeting Ligand-Functionalized Synthetic Antigen Receptor-Mesenchymal Stem Cells
por: Nethi, Susheel Kumar, et al.
Publicado: (2023) -
Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing
por: Prabha, Swayam, et al.
Publicado: (2023) -
Nanomedicine Strategies for Targeting Tumor Stroma
por: Su, Mei-Chi, et al.
Publicado: (2023)